![](https://www.cyclomedica.com/wp-content/uploads/2024/05/CYC-SYMPOSIUM-post-720x346.jpg)
Events
|
25th May 2024
By offering the insights from this webinar, we aim to provide our shareholders with a thorough grasp of Cyclopharm’s strategic trajectory and the considerable prospects that await us. Please download the full presentation to gain a deeper understanding of the profound significance of the USFDA approval as Cyclopharm advances into the next phase of our strategic growth journey.